Frazier Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Frazier Management’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell
2021 Q4	$39.3M	Buy
2021 Q3	$17.9M	Buy